FEops

📣 Positive impact of the 𝗙𝗘𝗼𝗽𝘀 𝗛𝗘𝗔𝗥𝗧𝗴𝘂𝗶𝗱𝗲™ FUSION in left atrial appendage occlusion 👉 New publication in the International Journal of Cardiology: "Tackling conFUSION and rendering the goal in left atrial appendage occlusion: A role for FEops-FUSION computational modelling?"   👏 Congratulations to Dr. Ian Buysschaert and Dr. Emmanuel De Cock, AZ Sint-Jan Brugge - Brugge, Belgium    https://lnkd.in/eNYiGwqz

Another successful congress for FEops ! At this year’s PCR London Valves, we showcased an advanced patient-specific computer simulation of a redo TAVR procedure, FEops HEARTguide — now part of the Materialise portfolio! Insightful interactions and presentations: 💡 Pr Mohamed Abdel-Wahab, sharing the future of 𝗧𝗔𝗩𝗥 𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝘃𝗲 𝗽𝗹𝗮𝗻𝗻𝗶𝗻𝗴 𝗶𝗻 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝘄𝗶𝘁𝗵 𝗹𝗼𝗻𝗴 𝗹𝗶𝗳𝗲 𝗲𝘅𝗽𝗲𝗰𝘁𝗮𝗻𝗰𝘆.   A special thanks to Pr D. Blackman, University of Leeds England - Pr Mohamed Abdel-Wahab, University of Leipzig Germany – Dr Matti Adam, University Hospital Cologne Germany. 🙏 Medtronic Team - Violaine Carlier Fouquet Carlier, Annemieke van der Heijden.   𝘕𝘰𝘵𝘦: 𝘛𝘩𝘦 𝘴𝘪𝘮𝘶𝘭𝘢𝘵𝘪𝘰𝘯 𝘰𝘧 𝘳𝘦𝘥𝘰 𝘛𝘈𝘝𝘙 𝘪𝘴 𝘯𝘰𝘵 𝘺𝘦𝘵 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘭𝘦 𝘧𝘰𝘳 𝘤𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘶𝘴𝘦 𝘪𝘯 𝘍𝘌𝘰𝘱𝘴 𝘏𝘌𝘈𝘙𝘛𝘨𝘶𝘪𝘥𝘦.   #TAVR #LifetimeManagement #PCRLondonValves #PCRLV

📢 Join us at PCR London Valves | November 24 – 26, 2024.  💡 Ready to explore all the latest innovations | Booth A27.    👉 FEops on stage! Don’t miss the following sessions: ► 𝗧𝗔𝗩𝗜 𝗶𝗻 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝘄𝗶𝘁𝗵 𝗹𝗼𝗻𝗴 𝗹𝗶𝗳𝗲 𝗲𝘅𝗽𝗲𝗰𝘁𝗮𝗻𝗰𝘆 𝘚𝘺𝘮𝘱𝘰𝘴𝘪𝘶𝘮 𝘸𝘪𝘵𝘩 𝘓𝘐𝘝𝘌 𝘤𝘢𝘴𝘦, 𝘖𝘱𝘦𝘳𝘢𝘵𝘰𝘳𝘴: 𝘔. 𝘈𝘥𝘢𝘮 - 𝘚. 𝘉𝘢𝘭𝘥𝘶𝘴 - 𝘌. 𝘒𝘶𝘩𝘯 Monday 25th | MAIN ARENA | 13:30 - 15:00 ► 𝗣𝗹𝗮𝗻𝗻𝗶𝗻𝗴 𝗳𝗼𝗿 𝘀𝗲𝗰𝗼𝗻𝗱 𝘁𝗶𝗺𝗲 𝗧𝗔𝗩𝗜 (𝗧𝗔𝗩-𝗶𝗻-𝗧𝗔𝗩) 𝗽𝗿𝗼𝗰𝗲𝗱𝘂𝗿𝗲𝘀 𝘍𝘢𝘤𝘪𝘭𝘪𝘵𝘢𝘵𝘰𝘳𝘴: 𝘈. 𝘉𝘦𝘯𝘦𝘥𝘶𝘤𝘦, 𝘈. 𝘒𝘩𝘰𝘬𝘩𝘢𝘳 Tuesday 26th | HANDS ON LAB | 08:30 - 09:00 & 09:10 - 09:40   Feel free to contact us or visit our booth Nico Uwents, Matthieu De Beule, Roberto Fiorucci

📢 Join us at PCR London Valves | November 24 – 26, 2024.  💡 Ready to explore all the latest innovations | Booth A27.    👉 FEops on stage! Don’t miss the following sessions: ► 𝗧𝗔𝗩𝗜 𝗶𝗻 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝘄𝗶𝘁𝗵 𝗹𝗼𝗻𝗴 𝗹𝗶𝗳𝗲 𝗲𝘅𝗽𝗲𝗰𝘁𝗮𝗻𝗰𝘆 𝘚𝘺𝘮𝘱𝘰𝘴𝘪𝘶𝘮 𝘸𝘪𝘵𝘩 𝘓𝘐𝘝𝘌 𝘤𝘢𝘴𝘦, 𝘖𝘱𝘦𝘳𝘢𝘵𝘰𝘳𝘴: 𝘔. 𝘈𝘥𝘢𝘮 - 𝘚. 𝘉𝘢𝘭𝘥𝘶𝘴 - 𝘌. 𝘒𝘶𝘩𝘯 Monday 25th | MAIN ARENA | 13:30 - 15:00 ► 𝗣𝗹𝗮𝗻𝗻𝗶𝗻𝗴 𝗳𝗼𝗿 𝘀𝗲𝗰𝗼𝗻𝗱 𝘁𝗶𝗺𝗲 𝗧𝗔𝗩𝗜 (𝗧𝗔𝗩-𝗶𝗻-𝗧𝗔𝗩) 𝗽𝗿𝗼𝗰𝗲𝗱𝘂𝗿𝗲𝘀 𝘍𝘢𝘤𝘪𝘭𝘪𝘵𝘢𝘵𝘰𝘳𝘴: 𝘈. 𝘉𝘦𝘯𝘦𝘥𝘶𝘤𝘦, 𝘈. 𝘒𝘩𝘰𝘬𝘩𝘢𝘳 Tuesday 26th | HANDS ON LAB | 08:30 - 09:00 & 09:10 - 09:40   Feel free to contact us or visit our booth Nico Uwents, Matthieu De Beule, Roberto Fiorucci

💡 Enhance the likelihood of achieving the 𝗼𝗽𝘁𝗶𝗺𝗮𝗹 𝘀𝗶𝘇𝗲 and 𝗶𝗺𝗽𝗹𝗮𝗻𝘁 𝗽𝗼𝘀𝗶𝘁𝗶𝗼𝗻 for LAAC devices with FEops 𝗛𝗘𝗔𝗥𝗧𝗴𝘂𝗶𝗱𝗲™ predictive simulations. 👉 Now in the International Journal of Cardiology, Learn more https://lnkd.in/e2b5_TDc Key Findings: ➤ The fusion of a 3D computational model on real time fluoroscopy is 𝘀𝗮𝗳𝗲 and 𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲 to guide LAAC ➤ This approach is associated with 𝗹𝗼𝘄 𝗰𝗼𝗺𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗿𝗮𝘁𝗲𝘀 and promising device-related outcomes (low rate of PDL and DRT) ➤ 𝗔𝗜-𝗲𝗻𝗮𝗯𝗹𝗲 𝗽𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝗼𝗻 provides individualized information to 𝗳𝗮𝗰𝗶𝗹𝗶𝘁𝗮𝘁𝗲 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗺𝗮𝗸𝗶𝗻𝗴  ➤ This approach has shown promise in 𝗶𝗺𝗽𝗿𝗼𝘃𝗶𝗻𝗴 𝗶𝗻𝘁𝗲𝗿𝘃𝗲𝗻𝘁𝗶𝗼𝗻𝗮𝗹 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀 🙏 A special Thanks to Emmanuel Gall and Philippe Garot Thanks to all co-authors Sandra Zendjebil Xavier Iriart Bruno Farah Carsten Skurk Alexandre Gautier Alessandra Bavo Regis Vaillant Jérôme Horvilleur Xavier Freixa Jacqueline Saw and Ole De Backer FEops Institut Cardiovasculaire Paris Sud (ICPS)

📣 𝗙𝗘𝗼𝗽𝘀 𝗛𝗘𝗔𝗥𝗧𝗴𝘂𝗶𝗱𝗲™ positively impacts Abbott Amplatzer™ Amulet™ size selection in LAAO compared to TEE- and/or CT-based SoC assessment.  👉 Now 𝗣𝗥𝗘𝗖𝗜𝗦𝗘-𝗟𝗔𝗔 Study Results in the JACC Cardiovascular Interventions. 👏 Congratulations to Dr. Ian Buysschaert, AZ Sint-Jan Brugge - Brugge, Belgium and investigators: ▫️ Emmanuel De Cock, Ghent University Hospital -Ghent, Belgium    ▫️ Stijn Lochyc, UZ Brussel - Brussel, Belgium ▫️ Maximo Rivero Ayerza, Ziekenhuis Oost-Limburg - Genk, Belgium ▫️ Mathieu Lempereur, CHU de Liège - Liège, Belgium ▫️ Kristoff Cornelis, AZ Maria Middelares - Gent, Belgium ▫️ Philippe Debonnaire, AZ Sint-Jan Brugge - Brugge , Belgium ▫️ Paul Vermeersch, ZNA Middelheim - Antwerpen, Belgium  ▫️ Emma Christiaen, AZ Sint-Jan Brugge - Brugge , Belgium   When Evidence Matters, Learn more https://lnkd.in/euNcgkjM   #Innovation #FEops #Abbott

📣 We are looking to hire an 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲𝗱, 𝗺𝗼𝘁𝗶𝘃𝗮𝘁𝗲𝗱 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘀𝗮𝗹𝗲𝘀 𝗽𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹 to 𝗱𝗿𝗶𝘃𝗲 𝘁𝗵𝗲 𝗰𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 of FEops 𝗛𝗘𝗔𝗥𝗧𝗴𝘂𝗶𝗱𝗲 in the 𝗨𝗦 𝗺𝗮𝗿𝗸𝗲𝘁. ▪ Are you looking for an exciting and innovation-driven work environment? ▪ Are you an experienced salesperson who can quickly uncover new opportunities? ▪ Do you have a successful track record in the clinical market? ▪ Are you experienced in networking with and presenting to physicians to successfully onboard them with new technology? Then we would like to speak with you! 👉 https://lnkd.in/erHtENnM

We are excited to announce that Materialise and FEops are joining forces. By bundling our forces with Materialise, we are well positioned to install the new standard in personalized treatment planning for structural heart interventions and accelerating our global commercialization. Integrating FEops’ cutting-edge technology into Materialise Mimics Planner for Structural Heart Interventions will offer clinicians a comprehensive solution for anatomy-based 3D planning and AI-based simulation. This allows clinicians to simulate the interaction between a medical device and a patient’s anatomy. Read about the acquisition in our latest press release (https://lnkd.in/e9xTTN88) #MassPersonalization #StructuralHeart #MedicalInnovation

💡 “𝗗𝗼𝗻’𝘁 𝗱𝗼 𝗮 𝗟𝗔𝗔𝗢 𝘄𝗶𝘁𝗵𝗼𝘂𝘁 FEops”, states Dr Philip Currie - Hollywood Private Hospital, Perth – Australia. 𝘋𝘳 𝘊𝘶𝘳𝘳𝘪𝘦 𝘩𝘢𝘴 𝘢 30 𝘺𝘦𝘢𝘳 𝘣𝘢𝘤𝘬𝘨𝘳𝘰𝘶𝘯𝘥 𝘪𝘯 𝘤𝘢𝘳𝘥𝘪𝘰𝘭𝘰𝘨𝘺 𝘣𝘰𝘵𝘩 𝘪𝘯 𝘵𝘩𝘦 𝘜𝘯𝘪𝘵𝘦𝘥 𝘚𝘵𝘢𝘵𝘦𝘴 𝘢𝘯𝘥 𝘪𝘯 𝘈𝘶𝘴𝘵𝘳𝘢𝘭𝘪𝘢 𝘢𝘯𝘥 𝘪𝘴 𝘢𝘵 𝘵𝘩𝘦 𝘤𝘶𝘵𝘵𝘪𝘯𝘨 𝘦𝘥𝘨𝘦 𝘰𝘧 𝘦𝘤𝘩𝘰𝘤𝘢𝘳𝘥𝘪𝘰𝘨𝘳𝘢𝘱𝘩𝘺. “I strongly feel that despite LAAO being around a while, we are gaining important 𝗻𝗲𝘄 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 in how to get not good results but 𝗲𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝘁 𝗿𝗲𝘀𝘂𝗹𝘁𝘀. FEops has 𝘀𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝘁 𝗵𝗲𝗹𝗽𝗲𝗱 𝗶𝗻 𝘁𝗵𝗲𝘀𝗲 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝘀.” 🙏 Thanks for sharing your experience with FEops 𝗛𝗘𝗔𝗥𝗧𝗴𝘂𝗶𝗱𝗲. A special thanks to Murray Walker, Abbott Australia.   #Innovation #FEops #Abbott

💡 Very interesting LAA Closure session at #CSI2024 - Frankfurt 🙏 A special thanks to Jacqueline Saw - Vancouver General Hospital, Canada for sharing her experience in using FEops 𝗛𝗘𝗔𝗥𝗧𝗴𝘂𝗶𝗱𝗲™ in LAA intervention using Abbott Amulet™ device.   𝘓𝘈𝘈 𝘤𝘭𝘰𝘴𝘶𝘳𝘦 𝘵𝘦𝘤𝘩𝘯𝘪𝘤𝘢𝘭 – 𝘍𝘳𝘰𝘮 𝘢𝘯𝘢𝘵𝘰𝘮𝘪𝘤𝘢𝘭 𝘷𝘢𝘳𝘪𝘢𝘣𝘪𝘭𝘪𝘵𝘺 𝘵𝘰 𝘰𝘱𝘵𝘪𝘮𝘢𝘭 𝘓𝘈𝘈 𝘤𝘭𝘰𝘴𝘶𝘳𝘦. When will you start using FEops 𝗛𝗘𝗔𝗥𝗧𝗴𝘂𝗶𝗱𝗲™ for your patients? Contact us at info@feops.com #AI #FEops #Innovation #LAAO